Skip to main content
. 2016 Dec 8;9(2):213–230. doi: 10.1080/19420862.2016.1267089

Figure 6.

Figure 6.

Efficient production of anti-HER2/CD3 BsIgG1 v10 in stable CHO cell lines. (A) Waterfall plot of individual CHO clones showing the percentage of BsIgG present in the protein A-purified IgG pool as estimated by high-resolution liquid chromatography-MS.19 (B) Shake flask production of BsIgG anti-HER2/CD3 BsIgG1 v10 clones 3, 5 and 7 is stable over time. (C) Similar percentage of BsIgG1 for clone 7 cultured in either a shake flask or bioreactor.